PL371320A1 - Gen Streptomyces Avermitilis kierujący stosunkiemawermektyn B2:B1 - Google Patents

Gen Streptomyces Avermitilis kierujący stosunkiemawermektyn B2:B1

Info

Publication number
PL371320A1
PL371320A1 PL03371320A PL37132003A PL371320A1 PL 371320 A1 PL371320 A1 PL 371320A1 PL 03371320 A PL03371320 A PL 03371320A PL 37132003 A PL37132003 A PL 37132003A PL 371320 A1 PL371320 A1 PL 371320A1
Authority
PL
Poland
Prior art keywords
avermectins
ratio
streptomyces avermitilis
gene directing
avermitilis gene
Prior art date
Application number
PL03371320A
Other languages
English (en)
Other versions
PL211693B1 (pl
Inventor
Kim Jonelle Stutzman-Engwall
Claes Eric Daniel Gustafsson
Anke Krebber
Sun Ai Raillard
Jeremy Stephen Minshull
Seran Kim
Yan Chen
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of PL371320A1 publication Critical patent/PL371320A1/pl
Publication of PL211693B1 publication Critical patent/PL211693B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623Avermectin; Milbemycin; Ivermectin; C-076

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL371320A 2002-02-12 2003-01-31 Gen Streptomyces Avermitilis kierujący stosunkiem awermektyn B2:B1 PL211693B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35622202P 2002-02-12 2002-02-12

Publications (2)

Publication Number Publication Date
PL371320A1 true PL371320A1 (pl) 2005-06-13
PL211693B1 PL211693B1 (pl) 2012-06-29

Family

ID=27734621

Family Applications (1)

Application Number Title Priority Date Filing Date
PL371320A PL211693B1 (pl) 2002-02-12 2003-01-31 Gen Streptomyces Avermitilis kierujący stosunkiem awermektyn B2:B1

Country Status (25)

Country Link
US (2) US7388085B2 (pl)
EP (2) EP2050815B1 (pl)
JP (1) JP2005517406A (pl)
KR (1) KR100718378B1 (pl)
CN (2) CN102392028B (pl)
AR (1) AR038405A1 (pl)
AT (2) ATE530645T1 (pl)
AU (1) AU2003245052B2 (pl)
BR (1) BRPI0307620B8 (pl)
CA (1) CA2475214C (pl)
CY (2) CY1110454T1 (pl)
DE (1) DE60326824D1 (pl)
DK (2) DK2050815T3 (pl)
ES (2) ES2373629T3 (pl)
IL (3) IL162866A0 (pl)
ME (1) ME00472B (pl)
MX (1) MXPA04007777A (pl)
PL (1) PL211693B1 (pl)
PT (2) PT2050815E (pl)
RS (1) RS50813B (pl)
RU (1) RU2293117C2 (pl)
SI (2) SI2050815T1 (pl)
TW (1) TWI341330B (pl)
WO (1) WO2003068955A2 (pl)
ZA (1) ZA200405345B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL162866A0 (en) 2002-02-12 2005-11-20 Pfizer Prod Inc Streptomyces a vermitilis gene directing the ratioof b2:b1 avermectins
CN102241750B (zh) * 2010-05-14 2014-05-28 中国科学院微生物研究所 一种生产阿维菌素的基因工程方法及其专用菌株
CN102093997B (zh) * 2010-12-01 2013-03-13 中国科学院上海有机化学研究所 一种改造除虫链霉菌产生多拉菌素的方法
CN109576196B (zh) * 2019-01-25 2022-01-04 北大方正集团有限公司 一种生产多拉菌素的发酵培养基及多拉菌素的生产方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4429042A (en) 1978-09-08 1984-01-31 Merck & Co., Inc. Strain of Streptomyces for producing antiparasitic compounds
IN167980B (pl) 1987-01-23 1991-01-19 Pfizer
US5252474A (en) 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
SI9420059A (en) * 1993-10-05 1997-02-28 Pfizer Process and antiparasitic intermediates for doramectin
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
KR20040099389A (ko) * 1998-02-13 2004-11-26 화이자 프로덕츠 인코포레이티드 스트렙토마이세스 하이그로스코피쿠스 유전자
US6248579B1 (en) 1998-02-13 2001-06-19 Pfizer Inc Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
RU2156301C2 (ru) * 1998-06-09 2000-09-20 Мосин Владимир Александрович Штамм актиномицета streptomyces avermitilis ссм 4697 - продуцент авермектинов
US6197591B1 (en) 1998-09-14 2001-03-06 Pfizer Inc. Streptomyces avermitilis regulatory genes for increased avermectin production
HK1046710B (zh) * 1999-08-12 2005-05-13 Zoetis Services Llc 介导除虫菌素b2:b1比例的除虫链霉菌基因
BR0013551A (pt) 1999-08-13 2003-06-17 Vertex Pharma Inibidores de cinases n-terminal cjun (jnk) e outras cinases de proteìnas
IL162866A0 (en) * 2002-02-12 2005-11-20 Pfizer Prod Inc Streptomyces a vermitilis gene directing the ratioof b2:b1 avermectins

Also Published As

Publication number Publication date
ZA200405345B (en) 2005-06-14
CY1112491T1 (el) 2015-12-09
ES2321827T3 (es) 2009-06-12
IL162866A0 (en) 2005-11-20
AR038405A1 (es) 2005-01-12
CA2475214C (en) 2012-07-31
BRPI0307620B8 (pt) 2016-09-13
US20090017508A1 (en) 2009-01-15
PL211693B1 (pl) 2012-06-29
EP2050815A1 (en) 2009-04-22
DK2050815T3 (da) 2011-12-12
ME00472B (me) 2011-10-10
RS50813B (sr) 2010-08-31
ATE530645T1 (de) 2011-11-15
BR0307620A (pt) 2004-12-07
DK1476539T3 (da) 2009-05-11
CN102392028A (zh) 2012-03-28
HK1168383A1 (en) 2012-12-28
CY1110454T1 (el) 2015-04-29
EP1476539A2 (en) 2004-11-17
PT1476539E (pt) 2009-04-09
IL192371A0 (en) 2008-12-29
IL162866A (en) 2009-11-18
EP2050815B1 (en) 2011-10-26
WO2003068955A2 (en) 2003-08-21
ES2373629T3 (es) 2012-02-07
EP1476539B1 (en) 2009-03-25
RU2293117C2 (ru) 2007-02-10
CN1630712B (zh) 2011-09-28
WO2003068955A3 (en) 2003-11-13
TWI341330B (en) 2011-05-01
CA2475214A1 (en) 2003-08-21
AU2003245052A1 (en) 2003-09-04
DE60326824D1 (de) 2009-05-07
RU2004124521A (ru) 2005-04-10
CN102392028B (zh) 2013-08-14
SI1476539T1 (sl) 2009-06-30
KR100718378B1 (ko) 2007-05-14
CN1630712A (zh) 2005-06-22
SI2050815T1 (sl) 2012-01-31
ATE426659T1 (de) 2009-04-15
PT2050815E (pt) 2012-01-02
US20030166165A1 (en) 2003-09-04
KR20040081199A (ko) 2004-09-20
US8008078B2 (en) 2011-08-30
US7388085B2 (en) 2008-06-17
TW200303918A (en) 2003-09-16
AU2003245052B2 (en) 2008-07-31
MXPA04007777A (es) 2004-10-15
HK1074644A1 (en) 2005-11-18
BRPI0307620B1 (pt) 2015-08-11
IL192371A (en) 2010-11-30
JP2005517406A (ja) 2005-06-16
RS70004A (sr) 2006-10-27

Similar Documents

Publication Publication Date Title
AU2002363246A1 (en) Game with multiple chambers
AU2003237249A1 (en) Oligonucleotides having modified nucleoside units
AU2003241621A1 (en) Oligonucleotides having modified nucleoside units
PT1594878E (pt) Derivados de monossacarídeo de avermectina tendo propriedades pesticidas
IL147562A0 (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
TWI341330B (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
IL137610A0 (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
HUP0202487A3 (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
AU2003279392A1 (en) Pharmaceutical compositions of azithromycin
AU2002317415A1 (en) Azalide antibiotic compositions
AU2003285599A1 (en) Novel semisynthetic macrolide antibiotics of the azalide series
AU2003304705A1 (en) 11-csubsituted erythromycin derivatives
ZA200507475B (en) Derivatives of azithromycin
SI1638984T1 (sl) Monosaharidni derivati avermektina B1
AU2003253701A1 (en) 11-c-substituted derivatives of clarithromycin
AU2003243789A1 (en) 11-c-substituted ketolides
DK1200605T3 (da) Streptomyces avermitilis gen, der dirigerer forholdet imellem B2:B1 avermectiner
AU2003267572A1 (en) Antibiotic derivatives of erythromycin
HK1071531A (en) Game with multiple chambers
AU2002236982A1 (en) Laulimalide derivatives
GB0221809D0 (en) Antibiotic derivatives
AU2003217311A1 (en) Base-labeled nucleosides and nucleotides
AU2002232183A1 (en) 12- and 13-modified novel 16-membered macrolide derivatives
GB0302008D0 (en) Antibiotic derivatives